Abstract #3811
Biomarkers of Aggressive Breast Cancer Revealed by Combining Magnetic Resonance Spectroscopic Imaging and Mass Spectrometric Imaging
Lu Jiang 1 , Kamila Chughtai 2 , Tiffany Greenwood 1 , Zaver M. Bhujwalla 1 , Venu Raman 1 , Gert Eijkel 2 , Ron Heeren 2 , and Kristine Glunde 1
1
Department of Radiology, Johns Hopkins
University School of Medic, BALTIMORE, MD, United
States,
2
FOM-Institute
AMOLF, Amsterdam, Netherlands
The total choline (tCho) signal in magnetic resonance
spectroscopic imaging (MRSI) of tumors is a potential
biomarker of breast cancer aggressiveness and can be
visualized in vivo by H1 MRSI tCho maps. Mass
spectrometry imaging (MSI) of histologic tumor sections
is able to detect thousands of biomolecules, including
tryptic peptides from on-tissue digested proteins, from
the tissue surface. We have investigated differentially
regulated proteins in high- versus low-tCho regions in a
human breast cancer model by combining in vivo MRSI with
ex vivo MSI, which identified specific protein species
that are spatially correlated with tCho.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
